
    
      Inclusion criteria is cerebrovascular insufficiency MNSE>20. 90 patients are divided into
      three groups randomly. First group is being administered 120 mg ginkgo biloba extract, second
      group 60 mg of the extract and the third group has being administered placebo during the
      period of 6 months. Methods used for evaluation are SCAG, MMSE, MDRS, VFT, CGI, TCD and color
      Doppler of carotid arteries. Methods used for follow up safety include: routine blood tests,
      biochemical tests, neurologic and physical examination, vital signs and ECG.
    
  